Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
29
WST Quote, Financials, Valuation and Earnings
Last price:
$243.75
Seasonality move
:
7.94%
Day range:
$241.91 - $247.18
52-week range:
$187.43 - $322.34
Dividend yield:
0.35%
P/E ratio:
35.89x
P/S ratio:
5.77x
P/B ratio:
5.53x
Volume:
760.8K
Avg. volume:
1.1M
1-year change:
20.42%
Market cap:
$17.6B
Revenue:
$3.1B
EPS (TTM):
$6.79
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
WST
West Pharmaceutical Services, Inc.
|
$794.8M | $1.83 | 11.64% | 36.4% | $318.36 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
BAX
Baxter International, Inc.
|
$2.8B | $0.54 | -0.44% | 26.94% | $21.63 |
|
BDX
Becton, Dickinson & Co.
|
$5.1B | $2.80 | -10.99% | 159.47% | $195.38 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.3% | 75.74% | $104.75 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.8B | $2.27 | 16.41% | 10.87% | $611.82 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
WST
West Pharmaceutical Services, Inc.
|
$243.83 | $318.36 | $17.6B | 35.89x | $0.22 | 0.35% | 5.77x |
|
ABT
Abbott Laboratories
|
$112.19 | $133.39 | $195.1B | 30.29x | $0.63 | 2.14% | 4.43x |
|
BAX
Baxter International, Inc.
|
$21.34 | $21.63 | $11B | 167.20x | $0.01 | 2.44% | 0.98x |
|
BDX
Becton, Dickinson & Co.
|
$182.47 | $195.38 | $51.9B | 29.80x | $0.83 | 1.8% | 2.39x |
|
BSX
Boston Scientific Corp.
|
$75.72 | $104.75 | $112.3B | 39.05x | $0.00 | 0% | 5.64x |
|
ISRG
Intuitive Surgical, Inc.
|
$499.53 | $611.82 | $177.4B | 63.42x | $0.00 | 0% | 18.00x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
WST
West Pharmaceutical Services, Inc.
|
9.31% | 1.536 | 1.73% | 2.11x |
|
ABT
Abbott Laboratories
|
20.25% | 0.141 | -- | 1.12x |
|
BAX
Baxter International, Inc.
|
61.48% | -0.563 | 99.84% | 1.33x |
|
BDX
Becton, Dickinson & Co.
|
43.59% | -0.585 | 44.99% | 0.40x |
|
BSX
Boston Scientific Corp.
|
33.07% | 0.200 | 8.46% | 0.94x |
|
ISRG
Intuitive Surgical, Inc.
|
0.95% | 0.941 | 0.08% | 3.73x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
WST
West Pharmaceutical Services, Inc.
|
$305.1M | $176.3M | 15.36% | 17% | 21.87% | $175M |
|
ABT
Abbott Laboratories
|
$6.5B | $2.4B | 10.2% | 29.06% | 20.59% | $2.3B |
|
BAX
Baxter International, Inc.
|
$870M | $117M | -5.13% | -12.97% | 3.93% | $444M |
|
BDX
Becton, Dickinson & Co.
|
$2.4B | $700M | 3.93% | 6.94% | 13.33% | $549M |
|
BSX
Boston Scientific Corp.
|
$3.6B | $1.2B | 8.3% | 12.55% | 22.93% | $1B |
|
ISRG
Intuitive Surgical, Inc.
|
$1.9B | $864.3M | 16.53% | 16.59% | 30.16% | $730M |
West Pharmaceutical Services, Inc. vs. Competitors
-
Which has Higher Returns WST or ABT?
Abbott Laboratories has a net margin of 16.39% compared to West Pharmaceutical Services, Inc.'s net margin of 15.5%. West Pharmaceutical Services, Inc.'s return on equity of 17% beat Abbott Laboratories's return on equity of 29.06%.
Company Gross Margin Earnings Per Share Invested Capital WSTWest Pharmaceutical Services, Inc.37.85% $1.82 $3.5B ABTAbbott Laboratories57.09% $1.02 $64.2B -
What do Analysts Say About WST or ABT?
West Pharmaceutical Services, Inc. has a consensus price target of $318.36, signalling upside risk potential of 30.57%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 18.9%. Given that West Pharmaceutical Services, Inc. has higher upside potential than Abbott Laboratories, analysts believe West Pharmaceutical Services, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings WSTWest Pharmaceutical Services, Inc.11 3 0 ABTAbbott Laboratories16 7 0 -
Is WST or ABT More Risky?
West Pharmaceutical Services, Inc. has a beta of 1.181, which suggesting that the stock is 18.063% more volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.138%.
-
Which is a Better Dividend Stock WST or ABT?
West Pharmaceutical Services, Inc. has a quarterly dividend of $0.22 per share corresponding to a yield of 0.35%. Abbott Laboratories offers a yield of 2.14% to investors and pays a quarterly dividend of $0.63 per share. West Pharmaceutical Services, Inc. pays 12.66% of its earnings as a dividend. Abbott Laboratories pays out 64.34% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios WST or ABT?
West Pharmaceutical Services, Inc. quarterly revenues are $806M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. West Pharmaceutical Services, Inc.'s net income of $132.1M is lower than Abbott Laboratories's net income of $1.8B. Notably, West Pharmaceutical Services, Inc.'s price-to-earnings ratio is 35.89x while Abbott Laboratories's PE ratio is 30.29x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for West Pharmaceutical Services, Inc. is 5.77x versus 4.43x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WSTWest Pharmaceutical Services, Inc.5.77x 35.89x $806M $132.1M ABTAbbott Laboratories4.43x 30.29x $11.5B $1.8B
-
Which has Higher Returns WST or BAX?
Baxter International, Inc. has a net margin of 16.39% compared to West Pharmaceutical Services, Inc.'s net margin of -34.8%. West Pharmaceutical Services, Inc.'s return on equity of 17% beat Baxter International, Inc.'s return on equity of -12.97%.
Company Gross Margin Earnings Per Share Invested Capital WSTWest Pharmaceutical Services, Inc.37.85% $1.82 $3.5B BAXBaxter International, Inc.29.25% -$2.16 $15.9B -
What do Analysts Say About WST or BAX?
West Pharmaceutical Services, Inc. has a consensus price target of $318.36, signalling upside risk potential of 30.57%. On the other hand Baxter International, Inc. has an analysts' consensus of $21.63 which suggests that it could grow by 1.38%. Given that West Pharmaceutical Services, Inc. has higher upside potential than Baxter International, Inc., analysts believe West Pharmaceutical Services, Inc. is more attractive than Baxter International, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WSTWest Pharmaceutical Services, Inc.11 3 0 BAXBaxter International, Inc.2 13 1 -
Is WST or BAX More Risky?
West Pharmaceutical Services, Inc. has a beta of 1.181, which suggesting that the stock is 18.063% more volatile than S&P 500. In comparison Baxter International, Inc. has a beta of 0.593, suggesting its less volatile than the S&P 500 by 40.747%.
-
Which is a Better Dividend Stock WST or BAX?
West Pharmaceutical Services, Inc. has a quarterly dividend of $0.22 per share corresponding to a yield of 0.35%. Baxter International, Inc. offers a yield of 2.44% to investors and pays a quarterly dividend of $0.01 per share. West Pharmaceutical Services, Inc. pays 12.66% of its earnings as a dividend. Baxter International, Inc. pays out 180.98% of its earnings as a dividend. West Pharmaceutical Services, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Baxter International, Inc.'s is not.
-
Which has Better Financial Ratios WST or BAX?
West Pharmaceutical Services, Inc. quarterly revenues are $806M, which are smaller than Baxter International, Inc. quarterly revenues of $3B. West Pharmaceutical Services, Inc.'s net income of $132.1M is higher than Baxter International, Inc.'s net income of -$1B. Notably, West Pharmaceutical Services, Inc.'s price-to-earnings ratio is 35.89x while Baxter International, Inc.'s PE ratio is 167.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for West Pharmaceutical Services, Inc. is 5.77x versus 0.98x for Baxter International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WSTWest Pharmaceutical Services, Inc.5.77x 35.89x $806M $132.1M BAXBaxter International, Inc.0.98x 167.20x $3B -$1B
-
Which has Higher Returns WST or BDX?
Becton, Dickinson & Co. has a net margin of 16.39% compared to West Pharmaceutical Services, Inc.'s net margin of 7.27%. West Pharmaceutical Services, Inc.'s return on equity of 17% beat Becton, Dickinson & Co.'s return on equity of 6.94%.
Company Gross Margin Earnings Per Share Invested Capital WSTWest Pharmaceutical Services, Inc.37.85% $1.82 $3.5B BDXBecton, Dickinson & Co.45.91% $1.34 $44.8B -
What do Analysts Say About WST or BDX?
West Pharmaceutical Services, Inc. has a consensus price target of $318.36, signalling upside risk potential of 30.57%. On the other hand Becton, Dickinson & Co. has an analysts' consensus of $195.38 which suggests that it could grow by 7.08%. Given that West Pharmaceutical Services, Inc. has higher upside potential than Becton, Dickinson & Co., analysts believe West Pharmaceutical Services, Inc. is more attractive than Becton, Dickinson & Co..
Company Buy Ratings Hold Ratings Sell Ratings WSTWest Pharmaceutical Services, Inc.11 3 0 BDXBecton, Dickinson & Co.4 9 0 -
Is WST or BDX More Risky?
West Pharmaceutical Services, Inc. has a beta of 1.181, which suggesting that the stock is 18.063% more volatile than S&P 500. In comparison Becton, Dickinson & Co. has a beta of 0.248, suggesting its less volatile than the S&P 500 by 75.233%.
-
Which is a Better Dividend Stock WST or BDX?
West Pharmaceutical Services, Inc. has a quarterly dividend of $0.22 per share corresponding to a yield of 0.35%. Becton, Dickinson & Co. offers a yield of 1.8% to investors and pays a quarterly dividend of $0.83 per share. West Pharmaceutical Services, Inc. pays 12.66% of its earnings as a dividend. Becton, Dickinson & Co. pays out 71.53% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios WST or BDX?
West Pharmaceutical Services, Inc. quarterly revenues are $806M, which are smaller than Becton, Dickinson & Co. quarterly revenues of $5.3B. West Pharmaceutical Services, Inc.'s net income of $132.1M is lower than Becton, Dickinson & Co.'s net income of $382M. Notably, West Pharmaceutical Services, Inc.'s price-to-earnings ratio is 35.89x while Becton, Dickinson & Co.'s PE ratio is 29.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for West Pharmaceutical Services, Inc. is 5.77x versus 2.39x for Becton, Dickinson & Co.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WSTWest Pharmaceutical Services, Inc.5.77x 35.89x $806M $132.1M BDXBecton, Dickinson & Co.2.39x 29.80x $5.3B $382M
-
Which has Higher Returns WST or BSX?
Boston Scientific Corp. has a net margin of 16.39% compared to West Pharmaceutical Services, Inc.'s net margin of 12.68%. West Pharmaceutical Services, Inc.'s return on equity of 17% beat Boston Scientific Corp.'s return on equity of 12.55%.
Company Gross Margin Earnings Per Share Invested Capital WSTWest Pharmaceutical Services, Inc.37.85% $1.82 $3.5B BSXBoston Scientific Corp.68.5% $0.45 $36.4B -
What do Analysts Say About WST or BSX?
West Pharmaceutical Services, Inc. has a consensus price target of $318.36, signalling upside risk potential of 30.57%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.75 which suggests that it could grow by 38.34%. Given that Boston Scientific Corp. has higher upside potential than West Pharmaceutical Services, Inc., analysts believe Boston Scientific Corp. is more attractive than West Pharmaceutical Services, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WSTWest Pharmaceutical Services, Inc.11 3 0 BSXBoston Scientific Corp.25 0 0 -
Is WST or BSX More Risky?
West Pharmaceutical Services, Inc. has a beta of 1.181, which suggesting that the stock is 18.063% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.
-
Which is a Better Dividend Stock WST or BSX?
West Pharmaceutical Services, Inc. has a quarterly dividend of $0.22 per share corresponding to a yield of 0.35%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. West Pharmaceutical Services, Inc. pays 12.66% of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend. West Pharmaceutical Services, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios WST or BSX?
West Pharmaceutical Services, Inc. quarterly revenues are $806M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. West Pharmaceutical Services, Inc.'s net income of $132.1M is lower than Boston Scientific Corp.'s net income of $670M. Notably, West Pharmaceutical Services, Inc.'s price-to-earnings ratio is 35.89x while Boston Scientific Corp.'s PE ratio is 39.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for West Pharmaceutical Services, Inc. is 5.77x versus 5.64x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WSTWest Pharmaceutical Services, Inc.5.77x 35.89x $806M $132.1M BSXBoston Scientific Corp.5.64x 39.05x $5.3B $670M
-
Which has Higher Returns WST or ISRG?
Intuitive Surgical, Inc. has a net margin of 16.39% compared to West Pharmaceutical Services, Inc.'s net margin of 27.89%. West Pharmaceutical Services, Inc.'s return on equity of 17% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.
Company Gross Margin Earnings Per Share Invested Capital WSTWest Pharmaceutical Services, Inc.37.85% $1.82 $3.5B ISRGIntuitive Surgical, Inc.66.41% $2.21 $18.1B -
What do Analysts Say About WST or ISRG?
West Pharmaceutical Services, Inc. has a consensus price target of $318.36, signalling upside risk potential of 30.57%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $611.82 which suggests that it could grow by 22.48%. Given that West Pharmaceutical Services, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe West Pharmaceutical Services, Inc. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings WSTWest Pharmaceutical Services, Inc.11 3 0 ISRGIntuitive Surgical, Inc.16 10 1 -
Is WST or ISRG More Risky?
West Pharmaceutical Services, Inc. has a beta of 1.181, which suggesting that the stock is 18.063% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.653, suggesting its more volatile than the S&P 500 by 65.303%.
-
Which is a Better Dividend Stock WST or ISRG?
West Pharmaceutical Services, Inc. has a quarterly dividend of $0.22 per share corresponding to a yield of 0.35%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. West Pharmaceutical Services, Inc. pays 12.66% of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend. West Pharmaceutical Services, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios WST or ISRG?
West Pharmaceutical Services, Inc. quarterly revenues are $806M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. West Pharmaceutical Services, Inc.'s net income of $132.1M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, West Pharmaceutical Services, Inc.'s price-to-earnings ratio is 35.89x while Intuitive Surgical, Inc.'s PE ratio is 63.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for West Pharmaceutical Services, Inc. is 5.77x versus 18.00x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income WSTWest Pharmaceutical Services, Inc.5.77x 35.89x $806M $132.1M ISRGIntuitive Surgical, Inc.18.00x 63.42x $2.9B $799.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
23
CAR alert for Feb 20
Avis Budget Group, Inc. [CAR] is down 2.28% over the past day.
Buy
75
HYMC alert for Feb 20
Hycroft Mining Holding Corp. [HYMC] is up 7% over the past day.
Sell
1
EPAM alert for Feb 20
EPAM Systems, Inc. [EPAM] is up 3.28% over the past day.
